The influence of MRI lesion size on the detection rate of prostate cancer using MRI/US fusion biopsydoi:10.1016/S1569-9056(18)33472-9Adamcová, V.Záleský, M.Stejskal, J.Pavličko, A.Votrubová, J.Matěj, R.Zachoval, R.Elsevier ScienceEuropean Urology Supplements...
INTRODUCTION AND OBJECTIVE: Multiparametric magnetic resonance imaging (mpMRI) is increasingly used in prostate cancer (PCa) diagnosis. MRI/ultrasound (US) fusion biopsy (FBx) technology can target suspicious lesions noted on pre-biopsy mpMRI. It seems intuitive that larger lesions on mpMRI would ...
Next, we compared the performance of the model on classifying prostate cancer on CTs with the performance of human experts (i.e. radiologists). Thus, for this experiment, we randomly selected 115 (or\(20\%\)) CT scans from the original dataset (one of the five folds used in the cross ...
Prostate cancer is known to be multi-focal and systematic biopsy serves to identify foci out of the index lesion which may not be well-visualised on MRI. To date, the critical clinical question of the optimal number of systematic biopsy cores remains an unanswered one, especially in the ...
Metastatic castrate-resistant prostate cancer (CRPC) is a disease state characterized by a testosterone level of less than 50 ng/dL, with 2 consecutive increases in prostate-specific antigen (PSA) with a PSA level of 2 ng/dL or more. ...
In 2023, Steve had a swelling in his cheek. It was diagnosed as parotid cancer. He wrote me and asked for help again. He took our herbs for about three months, but the tumour did not go away. He was okay but had occasional pain. But every morning when Steve woke up, he looked in...
Considering the usual characteristics of prostate cancer such as slow growing and osteoblastic metastasis, the application of FDG PET scan to this disease might be limited. However, in advanced prostate cancer refractory to chemotherapy, FDG PET scan show strong FDG uptake and SUV changes in serial...
The aim of this review is to report on the current status of prostate-specific membrane antigen (PSMA)-directed theranostics in prostate cancer (PC) patien
Prostate cancer is a heterogeneous cancer with widely varying levels of morbidity and mortality. Approaches to prostate cancer screening, diagnosis, surveillance, treatment and management differ around the world. To identify the highest priority research
Prostate cancer (PCa) is the most diagnosed urological malignancy in the male population [1]. Any clinical or biochemical suspicion of neoplasia requires further investigations via multiparametric magnetic resonance imaging (mpMRI) [2], each lesion being classified according to Prostate Imaging-Reporting...